跳转至内容
Merck
CN

88450

硫代乙酰胺

ACS reagent, ≥99.0%

别名:

乙硫酰胺

登录 查看组织和合同定价。

选择尺寸


关于此项目

线性分子式:
CH3CSNH2
化学文摘社编号:
分子量:
75.13
EC Number:
200-541-4
UNSPSC Code:
23151816
PubChem Substance ID:
Beilstein/REAXYS Number:
506006
MDL number:
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

InChI key

YUKQRDCYNOVPGJ-UHFFFAOYSA-N

InChI

1S/C2H5NS/c1-2(3)4/h1H3,(H2,3,4)

SMILES string

CC(N)=S

grade

ACS reagent

assay

≥99.0% (RT), ≥99.0%

form

crystals

ign. residue

≤0.05% (as SO4)

mp

111-114 °C

cation traces

Ca: ≤10 mg/kg, Cd: ≤5 mg/kg, Co: ≤5 mg/kg, Cr: ≤5 mg/kg, Cu: ≤5 mg/kg, Fe: ≤5 mg/kg, K: ≤50 mg/kg, Mg: ≤5 mg/kg, Mn: ≤5 mg/kg, Na: ≤100 mg/kg, Ni: ≤5 mg/kg, Pb: ≤5 mg/kg, Zn: ≤5 mg/kg

正在寻找类似产品? 访问 产品对比指南

Other Notes

用于分解氨基酸铜络合物

pictograms

Health hazardExclamation mark

signalword

Danger

Hazard Classifications

Acute Tox. 4 Oral - Aquatic Chronic 3 - Carc. 1B - Eye Irrit. 2 - Skin Irrit. 2

存储类别

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

法规信息

新产品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Decomposition of amino acid copper complexes using thioacetamide.
U F Taylor et al.
International journal of peptide and protein research, 19(2), 158-161 (1982-02-01)
Hong Ling et al.
PloS one, 8(1), e54499-e54499 (2013-01-26)
Considerable evidence has demonstrated that transforming growth factor β (TGF-β) plays a key role in hepatic fibrosis, the final common pathway for a variety of chronic liver diseases leading to liver insufficiency. Although a few studies have reported that blocking
Heather Hajovsky et al.
Chemical research in toxicology, 25(9), 1955-1963 (2012-08-08)
The hepatotoxicity of thioacetamide (TA) has been known since 1948. In rats, single doses cause centrolobular necrosis accompanied by increases in plasma transaminases and bilirubin. To elicit these effects, TA requires oxidative bioactivation, leading first to its S-oxide (TASO) and
Chiung-Kuei Huang et al.
Hepatology (Baltimore, Md.), 57(4), 1550-1563 (2012-11-15)
Transplantation of bone marrow mesenchymal stem cells (BM-MSCs) has been considered as an alternative therapy, replacing liver transplantation in clinical trials, to treat liver cirrhosis, an irreversible disease that may eventually lead to liver cancer development. However, low survival rate
Cun-hua Shao et al.
The Journal of surgical research, 186(1), 408-416 (2013-09-28)
Recent studies have demonstrated that bone marrow-derived mesenchymal stem cells (BM-MSCs) can potentially revert liver fibrosis, but it is not known if preparative hepatic irradiation (HIR) contributes to the therapeutic effect of transplanted BM-MSCs. In this study, we investigate the

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持